Physician profile
Shawn Patrick Wright
NPI 1528111499
$1,360.96
in general payments reported to CMS, 2019-2025
13 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $216 · 2022: $555 · 2023: $258 · 2024: $226 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $590.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $598.93 | 2021-2025 | |
| Impulse Dynamics (USA) INC. | $169.47 | 2022 | |
| Janssen Pharmaceuticals, INC | $160.16 | 2021-2022 | |
| Amgen INC. | $104.70 | 2021-2022 | |
| Cvrx, INC. | $88.99 | 2021-2024 | Barostim Neo System |
| Boston Scientific Corporation | $64.68 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $50.84 | 2022-2025 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.43 | 2023 | Lifevest |
| Kiniksa Pharmaceuticals, Ltd. | $22.62 | 2023 | Arcalyst |
| Novo Nordisk INC | $20.81 | 2023 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $20.36 | 2023 | |
| Pfizer INC. | $19.26 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $12.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.